KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Supernus Pharmaceuticals (SUPN) Long-Term Debt Issuances (2018)

Historic Long-Term Debt Issuances for Supernus Pharmaceuticals (SUPN) over the last 3 years, with Q1 2018 value amounting to $402.5 million.

  • Supernus Pharmaceuticals' Long-Term Debt Issuances changed N/A to $402.5 million in Q1 2018 from the same period last year, while for Dec 2018 it was $402.5 million, marking a year-over-year change of. This contributed to the annual value of $402.5 million for FY2018, which is N/A changed from last year.
  • As of Q1 2018, Supernus Pharmaceuticals' Long-Term Debt Issuances stood at $402.5 million.
  • In the past 5 years, Supernus Pharmaceuticals' Long-Term Debt Issuances registered a high of $402.5 million during Q1 2018, and its lowest value of $402.5 million during Q1 2018.